Authors:
RAJMAN I
HARPER L
MCPAKE D
KENDALL MJ
WHEELER DC
Citation: I. Rajman et al., LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILES IN CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 13(9), 1998, pp. 2281-2287
Citation: J. Misson et al., CLOPIDOGREL - SECONDARY PREVENTION OF VASCULAR ISCHEMIC EVENTS, Journal of clinical pharmacy and therapeutics, 23(2), 1998, pp. 91-95
Authors:
MARVIN G
SHARMA A
ASTON W
FIELD C
KENDALL MJ
JONES DA
Citation: G. Marvin et al., THE EFFECTS OF BUSPIRONE ON PERCEIVED EXERTION AND TIME TO FATIGUE INMAN, Experimental physiology, 82(6), 1997, pp. 1057-1060
Citation: Cj. Eagles et Mj. Kendall, THE EFFECTS OF COMBINED TREATMENT WITH BETA(1)-SELECTIVE RECEPTOR ANTAGONISTS AND LIPID-LOWERING DRUGS ON FAT-METABOLISM AND MEASURES OF FATIGUE DURING MODERATE INTENSITY EXERCISE - A PLACEBO-CONTROLLED STUDY IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 43(3), 1997, pp. 291-300
Citation: A. Head et al., EXERCISE METABOLISM IN HEALTHY-VOLUNTEERS TAKING CELIPROLOL, ATENOLOL, AND PLACEBO, British journal of sports medicine, 31(2), 1997, pp. 120-125
Citation: Mj. Kendall et Aq. Summerfield, DEVELOPMENT OF A TEST OF SPEECH-PERCEPTION FOR CHILDREN WITH COCHLEARIMPLANTS, British journal of audiology, 31(2), 1997, pp. 108-108
Authors:
KLEIN G
PFAFFEROTT C
BEIL S
GEHRING J
NIEMELA M
KENDALL MJ
Citation: G. Klein et al., EFFECT OF METOPROLOL AND AMLODIPINE ON MYOCARDIAL TOTAL ISCHEMIC BURDEN IN PATIENTS WITH STABLE ANGINA-PECTORIS, Journal of clinical pharmacy and therapeutics, 22(5-6), 1997, pp. 371-378
Citation: J. Misson et Mj. Kendall, THERAPEUTIC ADVANCES - DONEPEZIL FOR THE TREATMENT OF ALZHEIMERS-DISEASE, Journal of clinical pharmacy and therapeutics, 22(4), 1997, pp. 251-255
Citation: Mj. Landray et Mj. Kendall, BETA-BLOCKERS IN HEART-FAILURE - A CARDIOPROTECTIVE THERAPY, Journal of clinical pharmacy and therapeutics, 22(3), 1997, pp. 181-185
Citation: J. Misson et al., THERAPEUTIC ADVANCES - PROTEASE INHIBITORS FOR THE TREATMENT OF HIV-1INFECTION, Journal of clinical pharmacy and therapeutics, 22(2), 1997, pp. 109-117
Citation: Mj. Landray et Mj. Kendall, CORONARY-ARTERY DISEASE AND ANTIOXIDANTS - IS THERE A ROLE FOR CARVEDILOL - COMMENTARY, Journal of clinical pharmacy and therapeutics, 22(1), 1997, pp. 3-5
Citation: Re. Brown et al., COST-ANALYSIS OF ONCE-DAILY ISMN VERSUS TWICE-DAILY ISMN OR TRANSDERMAL PATCH FOR NITRATE PROPHYLAXIS, Journal of clinical pharmacy and therapeutics, 22(1), 1997, pp. 67-76
Authors:
WONG NACS
WILLOATS J
KENDALL MJ
SHEFFIELD EA
Citation: Nacs. Wong et al., AN IMMUNOHISTOCHEMICAL STUDY OF THE VASCULARIZATION OF WELL-DIFFERENTIATED THYROID-TUMORS, Journal of pathology, 182, 1997, pp. 43-43
Citation: Mj. Kendall, CLINICAL RELEVANCE OF PHARMACOKINETIC DIFFERENCES BETWEEN BETA-BLOCKERS, The American journal of cardiology, 80(9B), 1997, pp. 15-19
Authors:
RAJMAN I
LIP GYH
CRAMB R
MAXWELL SRJ
ZARIFIS J
BEEVERS DG
KENDALL MJ
Citation: I. Rajman et al., ADVERSE CHANGE IN LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS PROFILE WITH ESTROGEN-ONLY HORMONE REPLACEMENT THERAPY, Quarterly Journal of Medicine, 89(10), 1996, pp. 771-778
Citation: I. Rajman et al., ABNORMAL LDL SUBFRACTION PROFILES IN RENAL-TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3457-3457
Citation: Cj. Eagles et al., A COMPARISON OF THE EFFECTS OF FLUVASTATIN AND BEZAFIBRATE ON EXERCISE METABOLISM - A PLACEBO-CONTROLLED STUDY IN HEALTHY NORMOLIPIDEMIC SUBJECTS, British journal of clinical pharmacology, 41(5), 1996, pp. 381-387
Citation: A. Head et al., ACUTE EFFECTS OF BETA-BLOCKADE AND EXERCISE ON MOOD AND ANXIETY, British journal of sports medicine, 30(3), 1996, pp. 238-242
Citation: W. Clark et Mj. Kendall, GROWTH-HORMONE TREATMENT FOR GROWTH-HORMONE DEFICIENT ADULTS, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 367-372